Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 85 of the 86 references it cites were found in a registry or an index.

Functional and structural characterization of the integrase from the prototype foamy virus

Open access

Abstract

Establishment of the stable provirus is an essential step in retroviral replication, orchestrated by integrase (IN), a virus-derived enzyme. Until now, available structural information was limited to the INs of human immunodeficiency virus type 1 (HIV-1), avian sarcoma virus (ASV) and their close orthologs from the Lentivirus and Alpharetrovirus genera. Here, we characterized the in vitro activity of the prototype foamy virus (PFV) IN from the Spumavirus genus and determined the three-dimensional structure of its catalytic core domain (CCD). Recombinant PFV IN displayed robust and almost exclusively concerted integration activity in vitro utilizing donor DNA substrates as short as 16 bp, underscoring its significance as a model for detailed structural studies. Comparison of the HIV-1, ASV and PFV CCD structures highlighted both conserved as well as unique structural features such as organization of the active site and the putative host factor binding face. Despite possessing very limited sequence identity to its HIV counterpart, PFV IN was sensitive to HIV IN strand transfer inhibitors, suggesting that this class of inhibitors target the most conserved features of retroviral IN-DNA complexes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/nar/gkn938

Cites

85 of 85 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Strand transfer activity of recombinant PFV IN. (A) Schematic of strand transfer reactions using circular DNA target. Concerted integration results in a gapped linear product, and the half-site process yields tailed relaxed circles. (B) Concerted integration activity of PFV INΔ in vitro. The enzyme (1.5 μM) was incubated with supercoiled pGEM target DNA in the absence (lane 1) or presence of 100 nM donor DNA (lanes 2–5). Blunt DNA fragments of varying lengths mimicking the U5 PFV cDNA terminus served as donors: 120-bp (lane 2), 420-bp (lane 3), an equimolar mixture of 120-bp and 420-bp donors (50 nM each, lane 4), or a 32-bp oligonucleotide (lane 5). Reaction products separated in 1.5% agarose gels were detected with ethidium bromide. Migration positions of concerted and half-site reaction products, open circular (o.c.) and supercoiled (s.c.) pGEM target DNA forms, donor DNA and a DNA size ladder are indicated. (C) PFV INΔ strand transfer activity in the presence of 0–2.5 μM blunt 32-bp donor DNA (lanes 2–10, as indicated). IN was omitted in lane 1. Here and on the remaining panels, the star indicates the migration position of the concerted integration product. (D) Time course of PFV INΔ strand transfer reactions in the presence of preprocessed (lanes 1–9) and blunt (lanes 10–18) 32-bp donor DNA. IN was omitted in lanes 1 and 10. (E) Comparison of strand transfer activities of full-length PFV IN and INΔ. Supercoiled pGEM target DNA was incubated with 0.38–3 μM INΔ (lanes 2–5) or full-length PFV IN (lanes 6–9) in the absence (lanes 2 and 6) or presence (lanes 3–5, 7–9) of preprocessed 32-bp donor substrate; IN was omitted in lane 1. (F) Effect of donor DNA length. Strand transfer reactions using PFV INΔ and preprocessed donors of 32–14 bp, as indicated atop the gel. The enzyme was omitted in lane 1 and donor DNA was omitted in lane 2.
Figure 1. Strand transfer activity of recombinant PFV IN. (A) Schematic of strand transfer reactions using circular DNA target. Concerted integration results in a gapped linear product, and the half-site process yields tailed relaxed circles. (B) Concerted integration activity of PFV INΔ in vitro. The enzyme (1.5 μM) was incubated with supercoiled pGEM target DNA in the absence (lane 1) or presence of 100 nM donor DNA (lanes 2–5). Blunt DNA fragments of varying lengths mimicking the U5 PFV cDNA terminus served as donors: 120-bp (lane 2), 420-bp (lane 3), an equimolar mixture of 120-bp and 420-bp donors (50 nM each, lane 4), or a 32-bp oligonucleotide (lane 5). Reaction products separated in 1.5% agarose gels were detected with ethidium bromide. Migration positions of concerted and half-site reaction products, open circular (o.c.) and supercoiled (s.c.) pGEM target DNA forms, donor DNA and a DNA size ladder are indicated. (C) PFV INΔ strand transfer activity in the presence of 0–2.5 μM blunt 32-bp donor DNA (lanes 2–10, as indicated). IN was omitted in lane 1. Here and on the remaining panels, the star indicates the migration position of the concerted integration product. (D) Time course of PFV INΔ strand transfer reactions in the presence of preprocessed (lanes 1–9) and blunt (lanes 10–18) 32-bp donor DNA. IN was omitted in lanes 1 and 10. (E) Comparison of strand transfer activities of full-length PFV IN and INΔ. Supercoiled pGEM target DNA was incubated with 0.38–3 μM INΔ (lanes 2–5) or full-length PFV IN (lanes 6–9) in the absence (lanes 2 and 6) or presence (lanes 3–5, 7–9) of preprocessed 32-bp donor substrate; IN was omitted in lane 1. (F) Effect of donor DNA length. Strand transfer reactions using PFV INΔ and preprocessed donors of 32–14 bp, as indicated atop the gel. The enzyme was omitted in lane 1 and donor DNA was omitted in lane 2.CC BY-NC · PubMed Central
Figure 2. Sequence analysis of concerted integration products. (A) Histograms of duplication size distributions in cloned concerted integration products from reactions mediated by PFV INΔ utilizing pre-processed 32-bp (black bars), 24-bp (light gray), or 16-bp (dark gray) donor DNA substrates. (B) A sequence logo representing nucleotide base frequencies at PFV integration sites. Target DNA sequences (n = 168) as joined to the reactive strand of donor DNA (from all 84 analyzed clones) were used in the alignment. Black arrowhead indicates the nucleotide joined to donor DNA (position 0 of the alignment); gray arrowhead indicates the insertion position of the second donor molecule into the complementary strand (position +3). The height of each logo is proportional to the frequency of the corresponding nucleotide within the alignment, while the height of each stack of logos reflects the level of conservation at each position. The figure was created using WebLogo (83).
Figure 2. Sequence analysis of concerted integration products. (A) Histograms of duplication size distributions in cloned concerted integration products from reactions mediated by PFV INΔ utilizing pre-processed 32-bp (black bars), 24-bp (light gray), or 16-bp (dark gray) donor DNA substrates. (B) A sequence logo representing nucleotide base frequencies at PFV integration sites. Target DNA sequences (n = 168) as joined to the reactive strand of donor DNA (from all 84 analyzed clones) were used in the alignment. Black arrowhead indicates the nucleotide joined to donor DNA (position 0 of the alignment); gray arrowhead indicates the insertion position of the second donor molecule into the complementary strand (position +3). The height of each logo is proportional to the frequency of the corresponding nucleotide within the alignment, while the height of each stack of logos reflects the level of conservation at each position. The figure was created using WebLogo (83).CC BY-NC · PubMed Central
Figure 3. PFV IN is sensitive to HIV IN strand transfer inhibitors. (A) Inhibition of the in vitro strand transfer activity by GS9137 and MK0518. Preprocessed 32-bp donor DNA substrate was incubated with PFV INΔ and supercoiled target DNA in the presence (lanes 1–5 and 7–11) or absence (lanes 6 and 12) of inhibitors. Final drug concentrations were 0.008 µM (lanes 1 and 7), 0.04 µM (lanes 2 and 8), 0.2 µM (lanes 3 and 9), 1 µM (lanes 4 and 10) and 5 µM (lanes 5 and 11). DMSO was present in all reactions at a final concentration of 1%. (B) Infection of D17 cells by PFV-based retroviral vector in the presence of strand transfer inhibitors MK0518 (black line and circles) or GS9137 (gray line and diamonds). Infectivity in the absence of inhibitors was set to 100%. The dotted gray line represents 50% inhibition.
Figure 3. PFV IN is sensitive to HIV IN strand transfer inhibitors. (A) Inhibition of the in vitro strand transfer activity by GS9137 and MK0518. Preprocessed 32-bp donor DNA substrate was incubated with PFV INΔ and supercoiled target DNA in the presence (lanes 1–5 and 7–11) or absence (lanes 6 and 12) of inhibitors. Final drug concentrations were 0.008 µM (lanes 1 and 7), 0.04 µM (lanes 2 and 8), 0.2 µM (lanes 3 and 9), 1 µM (lanes 4 and 10) and 5 µM (lanes 5 and 11). DMSO was present in all reactions at a final concentration of 1%. (B) Infection of D17 cells by PFV-based retroviral vector in the presence of strand transfer inhibitors MK0518 (black line and circles) or GS9137 (gray line and diamonds). Infectivity in the absence of inhibitors was set to 100%. The dotted gray line represents 50% inhibition.CC BY-NC · PubMed Central
Figure 4. Crystal structure of the PFV IN CCD. (A) Stereo view of the PFV CCD structure. Secondary structure elements are color-coded: light blue for α-helices, magenta for β-strands, and orange for loops; the C-terminal α-helix comprised of residues 293–304 is painted gray. The catalytic site residues Asp-128, Asp-185 and Glu-221 are shown as red sticks. Gray spheres are Mg atoms. (B) Structures of the HIV-1 and ASV IN CCDs (PDB accession codes 1bl3 and 1vsd, respectively) (C) Structure-based amino acid sequence alignment of PFV, HIV-1, and RSV IN CCDs. Secondary structure elements (α, alpha helix; β, beta strand; η, 310 helix) are shown above the alignment. Residue numbering corresponds to the full-length PFV IN. Residues conserved across the alignment are shown in bold and highlighted in yellow and those of the catalytic D,DX35E motif in red. (D) Stereo view of the PFV IN active site. Protein structure is shown as sticks; the Mg atom and the associated water molecules are gray and red spheres, respectively. Residues discussed in the text are labeled. (E) Superposition of the PFV, HIV-1 and ASV IN active sites. Carbon and Mg atoms (spheres) are colored according to the viral species: PFV, green; HIV-1, blue; ASV, magenta. Residue numbering corresponds to HIV-1 IN. (A), (B), (D) and (E) were created with PyMOL (DeLano Scientific, http://www.pymol.org), and (C) with ESPript (84).
Figure 4. Crystal structure of the PFV IN CCD. (A) Stereo view of the PFV CCD structure. Secondary structure elements are color-coded: light blue for α-helices, magenta for β-strands, and orange for loops; the C-terminal α-helix comprised of residues 293–304 is painted gray. The catalytic site residues Asp-128, Asp-185 and Glu-221 are shown as red sticks. Gray spheres are Mg atoms. (B) Structures of the HIV-1 and ASV IN CCDs (PDB accession codes 1bl3 and 1vsd, respectively) (C) Structure-based amino acid sequence alignment of PFV, HIV-1, and RSV IN CCDs. Secondary structure elements (α, alpha helix; β, beta strand; η, 310 helix) are shown above the alignment. Residue numbering corresponds to the full-length PFV IN. Residues conserved across the alignment are shown in bold and highlighted in yellow and those of the catalytic D,DX35E motif in red. (D) Stereo view of the PFV IN active site. Protein structure is shown as sticks; the Mg atom and the associated water molecules are gray and red spheres, respectively. Residues discussed in the text are labeled. (E) Superposition of the PFV, HIV-1 and ASV IN active sites. Carbon and Mg atoms (spheres) are colored according to the viral species: PFV, green; HIV-1, blue; ASV, magenta. Residue numbering corresponds to HIV-1 IN. (A), (B), (D) and (E) were created with PyMOL (DeLano Scientific, http://www.pymol.org), and (C) with ESPript (84).CC BY-NC · PubMed Central
Figure 5. Comparison of the putative co-factor binding faces of Spumavirus (PFV) (A) and Alpharetrovirus (ASV) (B) IN CCDs to the LEDGF-binding face of the Lentivirus (HIV-1) IN CCD (C). Dimeric CCD structures are shown as cartoons; protein chains are painted blue and green; helices α3, α4 and α5 are indicated, α4/5 connectors (40) are shown in magenta. Side chains of residues involved or potentially involved in co-factor binding are shown as sticks. The figure was created using PyMOL.
Figure 5. Comparison of the putative co-factor binding faces of Spumavirus (PFV) (A) and Alpharetrovirus (ASV) (B) IN CCDs to the LEDGF-binding face of the Lentivirus (HIV-1) IN CCD (C). Dimeric CCD structures are shown as cartoons; protein chains are painted blue and green; helices α3, α4 and α5 are indicated, α4/5 connectors (40) are shown in magenta. Side chains of residues involved or potentially involved in co-factor binding are shown as sticks. The figure was created using PyMOL.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 86 references

Research works printed but not linked: 1

  1. Leslie, 1992, Recent changes to the MOSFLM package for processing film and image plate data, Joint CCP4 + ESF-EAMCB Newsletter on Protein Crystallography.

Cited by

See all 148

Metadata

Authors
Valkov, E., Gupta, S. S., Hare, S., Helander, A., Roversi, P., McClure, M., & Cherepanov, P.
Affiliations
  • Imperial College London (GB)
  • University of Oxford (GB)
Corresponding author
Cherepanov, Peter
Venue
Nucleic Acids Research
Published
2008-11-26
Volume
37
Issue
1
Pages
243-255
ISSN
  • 0305-1048 (ISSN-L)
  • 1362-4962
OpenAlex
W2001281718
Cited by
130
References
86
Citations by year
2026: 2 · 2024: 1 · 2023: 2 · 2021: 7 · 2020: 3 · 2019: 7 · 2018: 6 · 2017: 9 · 2016: 5 · 2015: 15 · 2014: 12 · 2013: 10 · 2012: 13
FWCI
4.27
Type
journal article
Language
en
Open access
Locations
  • Nucleic Acids Research (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Sussex Research Online (University of Sussex) (submittedVersion, cc-by-nc)
  • Figshare (submittedVersion, cc-by-nc)
Funders
European Synchrotron Radiation Facility
Topics
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Keywords
retroviral integrase, integrase strand transfer inhibitors, HIV-1 integrase, proviral integration
MeSH terms
Amino Acid Sequence, Animals, Cell Line, Crystallography, Dogs, Enzyme Inhibitors, Humans, Models, Molecular, Molecular Sequence Data, Recombinant Proteins, Viral Proteins, Spumavirus, Sequence Analysis, DNA, Integrases, Catalytic Domain

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Functional and structural characterization of the integrase from the prototype foamy virus. https://app.cochat.ai/papers/10.1093/nar/gkn938
The paper
Valkov, E., Gupta, S. S., Hare, S., Helander, A., Roversi, P., McClure, M., & Cherepanov, P. (2009). Functional and structural characterization of the integrase from the prototype foamy virus. Nucleic Acids Research. https://doi.org/10.1093/nar/gkn938

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.